October 2024 — CDMO Opportunities And Threats Report
Contractor BioPharma Company Event Product* Relationship POTENTIALLY POSITIVE Alfasigma SpA Windtree Therapeutics Inc Positive Phase II top-line results of the drug in early cardiogenic shock and Acute Heart Failure istaroxime Small mol API Almac Group Ltd …